Reply to “Improving Risk Estimation in MASLD: Competing Events and Liver Function Reserve”

IF 33 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-05-20 DOI:10.1016/j.jhep.2025.05.006

Axel Wester, Gabriel Issa, Hannes Hagström

{"title":"Reply to “Improving Risk Estimation in MASLD: Competing Events and Liver Function Reserve”","authors":"Axel Wester, Gabriel Issa, Hannes Hagström","doi":"10.1016/j.jhep.2025.05.006","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors' contributions</h2>Axel Wester drafted the manuscript. All authors critically reviewed the manuscript and approved it before submission.</section></section><section><section><h2>Financial support</h2>AW was supported by the Syskonen Svensson foundation for medical research (2021-00284), Mag-Tarmfonden, the Bengt Ihre foundation (SLS-973809, SLS-999079), the Professor Nanna Svartz foundation (2022-00448), Region Stockholm (CIMED) (FoUI-985859), and Gastroenterologisk forskningsfond (SLS-999141). HH was supported by grants from Region Stockholm (FoUI-960537), the Swedish Research Council (2021-01293), and the Swedish Cancer Society (2 2210 Pj 01 H). The funders had no role in the conduct of</section></section><section><section><h2>Declaration of Competing Interest</h2>HH:s institutions have received research funding from Astra Zeneca, EchoSens, Gilead, Intercept, MSD and Pfizer. HH has served as consultant for Astra Zeneca and has been part of hepatic events adjudication committees for KOWA and GW Pharma. The other authors declare no conflict of interests. Please refer to the accompanying ICMJE disclosure forms for further details.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"55 1","pages":""},"PeriodicalIF":33.0000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.05.006","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Authors' contributions

Axel Wester drafted the manuscript. All authors critically reviewed the manuscript and approved it before submission.

Financial support

AW was supported by the Syskonen Svensson foundation for medical research (2021-00284), Mag-Tarmfonden, the Bengt Ihre foundation (SLS-973809, SLS-999079), the Professor Nanna Svartz foundation (2022-00448), Region Stockholm (CIMED) (FoUI-985859), and Gastroenterologisk forskningsfond (SLS-999141). HH was supported by grants from Region Stockholm (FoUI-960537), the Swedish Research Council (2021-01293), and the Swedish Cancer Society (2 2210 Pj 01 H). The funders had no role in the conduct of

Declaration of Competing Interest

HH:s institutions have received research funding from Astra Zeneca, EchoSens, Gilead, Intercept, MSD and Pfizer. HH has served as consultant for Astra Zeneca and has been part of hepatic events adjudication committees for KOWA and GW Pharma. The other authors declare no conflict of interests. Please refer to the accompanying ICMJE disclosure forms for further details.

查看原文本刊更多论文

回复“改进MASLD的风险评估：竞赛项目与肝功能储备”

部分片段作者的贡献萨克斯·韦斯特起草了手稿。所有作者在提交前都对稿件进行了严格的审查和批准。资金支持：Syskonen Svensson医学研究基金会（2021-00284），magg - tarmfonden， Bengt Ihre基金会（SLS-973809, SLS-999079）， Nanna Svartz教授基金会（2022-00448），斯德哥尔摩地区（CIMED）（FoUI-985859）和skingsfond胃肠病学（SLS-999141）。HH得到了斯德哥尔摩地区（FoUI-960537）、瑞典研究委员会（2021-01293）和瑞典癌症协会（2 2210 Pj 01 H）的资助。这些资助者在《竞争利益声明》的实施中没有任何作用。美国的研究机构已经从阿斯特拉-利康、EchoSens、吉利德、Intercept、默沙明和辉瑞获得了研究资金。HH曾担任Astra Zeneca的顾问，并一直是kova和GW Pharma的肝脏事件裁决委员会的一部分。其他作者声明没有利益冲突。详情请参阅随附的ICMJE披露表格。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.